Equity
-€3,135
Debts exceed assets in financial year 2025.
Parry
Lifetime
20 annual accounts with figures on one time axispeak €146,573 (2019)
€127,519▲ 12.7%
lowest -€47,172 (2009)
€11,442▲ 6.9%
peak €15,020 (2006)
-€3,135▲ €11,442
€231,618▲ 11.1%
peak 1.2 FTE (2008)
1.1 FTE▲ 22.2%
Board1 name since 2009
1 director
Owners
100%
Documentsfilings and deeds
29-07-20262 days before the deadline
2025abbreviated format
Gross margin from €113,133 to €127,519Staff from 0.9 FTE to 1.1 FTEEquity from -€14,577 to -€3,135Cash from €9,661 to €4,893
Key points
from the 2025 annual accountsProfit
7 years
7 profitable years in a row. Profit 2025: €11,442.
Turnover
≈ €600,000 estimated
The accounts state no turnover.
Debts
€231,618 101% of the balance sheet
Financial debts 43%Suppliers 33%Taxes and wages 12%Other 11%
Of this, €229,556 falls due within a year.
Filings
20 annual accounts since 2006
The 2024 accounts came 18 days late. The other nine of the last ten were filed on time.
Position in the sector
-1.4%
Lower solvency than 89% of companies in retail trade. Sector median 36.9% · 13,234 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,795 companies had the same profile as Parry has now. Each dot stands for 10 companies, two years later.
91.4%
were still trading
5.4%
stopped another way
2.7%
went bankrupt
Another 0.6% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,795 companies, not a prediction for Parry. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 30-06-2009
- 100%equity -€46,800 (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0880161865
Appointment: (director)
“L'exploitation d'officines pharmaceutiques,d'orthopédie,de droguerie,d'herboristerie,de phytothérapie,de…” (deed in French) · Gazette deed
Incorporation
published on 03-04-2006 · Gazette deed
First establishment
Pharmacie HAVAUX, Generaal Gratrystraat 1, Schaerbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Parry Schaerbeek | €228,483 | €127,519 | -1.4% | 1.1 |
| PHARMACIE COLONIALE Ixelles | €261,567 | €128,561 | 86.3% | 1.2 |
| Apotheek de Vaart Leuven | €271,903 | €136,086 | 36.7% | 1 |
| PHARMACIE DE BROUCKERE Brussels | €300,319 | €132,060 | 0.6% | 1.5 |
| APOTHEEK CERESA-VAN BOSSTRAETEN Sint-Truiden | €283,756 | €160,440 | 22.7% | 1 |
| Apotheek Anselmo Antwerp | €249,318 | €115,790 | 60.3% | 1 |
| APOTHEEK HAVENDAM Bruges | €263,053 | €93,021 | 75.6% | 0.8 |
These companies have the same main activity as Parry: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €249,000 and €300,000, founded between 1998 and 2007.
Official details
Source: KBO- Status
- Active since 22-03-2006Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.179.981.9581030 Schaerbeek, since 20-03-2006
- Financial year end
- 31 December
- Peppol
- Reachable since 11-12-2025
Annual accounts 2025
- €228,483▲ 17.8%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 29-07-2026, 2 days before the end of the filing period
Insights on Parry
Parry files the abbreviated format. That format states no turnover. The gross margin rose from €102,872 in 2006 to €127,519 in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Parry
- What is the company number of Parry?
- The company number of Parry is 0880.161.865. The VAT number is the same number with BE in front: BE 0880.161.865.
- Where is Parry based?
- The registered office is at Generaal Gratrystraat 1, 1030 Schaerbeek.Company details
- What does Parry do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Parry?
- Parry is a private limited company (BV).
- When was Parry founded?
- Parry was founded on 22-03-2006.
- Is Parry still active?
- Yes, Parry is an active enterprise in the KBO register.
- How many employees does Parry have?
- Parry had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Parry fall under?
- In its 2025 annual accounts, Parry states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Parry?
- The turnover in financial year 2025 is ≈ €600,000. This figure is estimated from the gross margin of €127,519 and 51 comparable companies (NACE 477). It probably lies between €400,000 and €1.2m.
- Is Parry profitable?
- In financial year 2025, Parry made a profit of €11,442.
- Where can I find the annual accounts of Parry?
- Parry filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Parry due?
- Parry must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.